CureVac N.V.
CVACNASDAQHealthcare
$4.66
+$0.00(+0.00%)
Market Cap$1.0B
P/E Ratio—
52W High$5.72
52W Low$2.475
CureVac N.V.（CVAC）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CVAC · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.19B | ($0.26B) | ($0.25B) | ($0.41B) | ($0.13B) |
| Depreciation & Amort. | $0.02B | $0.02B | $0.02B | $0.02B | $0.01B |
| Stock-Based Comp. | $0.00B | $0.01B | $0.01B | $0.01B | $0.01B |
| Change in Working Capital | ($0.16B) | ($0.07B) | ($0.13B) | ($0.07B) | $0.58B |
| Net Cash from Operations | $0.10B | ($0.27B) | ($0.29B) | ($0.73B) | $0.52B |
| Investing Activities | |||||
| Capital Expenditure | ($0.02B) | ($0.06B) | ($0.09B) | ($0.13B) | ($0.05B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.02B) | ($0.06B) | ($0.09B) | ($0.13B) | ($0.05B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | ($0.03B) | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.01B) | ($0.01B) | ($0.00B) | ($0.03B) | ($0.05B) |
| Net Cash from Financing | ($0.01B) | $0.23B | $0.06B | $0.34B | $0.82B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.08B | ($0.32B) | ($0.38B) | ($0.86B) | $0.48B |
| FCF Margin %(computed) | 15.58% | -601.00% | -562.74% | -836.03% | 971.47% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · EUR · B
深入了解CureVac N.V.
关于CureVac N.V.（CVAC）现金流量表
CureVac N.V. 2024财年经营活动现金流$0.10B，自由现金流$0.08B（FCF利润率15.58%），资本支出($0.02B)。
常见问题
CVAC · 4 问CureVac N.V. 2024财年自由现金流$0.08B，同比up125.8%。
CVAC free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10